Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
603669 Lionco Pharmaceutical Group
- 4.62
- +0.42+10.00%
Not Open Apr 24 15:00 CST
3.33BMarket Cap-25.52P/E (TTM)
4.62High4.22Low202.74KlotVolume4.26Open4.20Pre Close91.48MTurnover2.81%Turnover RatioLossP/E (Static)721.24MShares9.5452wk High4.70P/B3.33BFloat Cap3.4552wk Low4.62Limit Up721.24MShs Float20.05Historical High3.78Limit Down9.52%Amplitude2.94Historical Low--Dividend TTM4.51Avg Price115.36KlotAsk--Div YieldTTM100Lot Size78.77KlotBid
Lionco Pharmaceutical Group News
Insider Information Insider Registration Management System (Revised in April 2025)
General Manager Work Rules (Revised April 2025)
Rules of work for board secretaries (revised in April 2025)
Fund Raising Management System (Revised in April 2025)
CITIC Securities Co., Ltd.\'s inspection opinions on the storage and use of funds raised by Lingkang Pharmaceutical Group Co., Ltd. in 2024
Special inspection report on the 2024 operating income deduction table of Lingkang Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 27th Meeting of the Fourth Board of Directors
Verification report on the storage and actual use of funds raised by Lingkang Pharmaceutical Group Co., Ltd.
Special report on the annual storage and use of raised funds
Lingkang Pharmaceutical Group Co., Ltd.\'s evaluation report on accounting firms
Report of the Audit Committee of the Board of Directors of Lingkang Pharmaceutical Group Co., Ltd. on the performance evaluation of the accounting firm
Special Opinions of the Board of Directors of Lingkang Pharmaceutical Group Co., Ltd. on the 2024 Independence Assessment of Independent Directors
Independent Director\'s 2024 Annual Debriefing Report - Pan Ziqiang
Independent Director\'s 2024 Annual Debriefing Report-Before
Report on the performance of the Audit Committee of the Board of Directors of the Company in 2024
Internal Control Audit Report of Lingkang Pharmaceutical Group Co., Ltd.
2024 Internal Control Evaluation Report
Independent Director\'s 2024 Annual Debriefing Report - He Chao
Special audit report on the summary table of non-operating capital occupation and other related capital transactions of Lingkang Pharmaceutical Group Co., Ltd.
2024 Annual Audit Report
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs